Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Sensitive

Metabolic syndrome (bivariate traits)

LPL · rs301

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−39, with 16 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 22,161 European ancestry individuals.

The effect Each copy of the C allele shifted the measure 0.22 lower (95% confidence interval 0.16-0.28); p = 3 × 10−11.

Where it sits Chromosome 8, band 8p21.3 — in an intron of LPL.

What ClinVar records

Classification Benign; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 2 submitters), last evaluated 2018-08-30. ClinVar record 1278475 NM_000237.3(LPL):c.1139+43T>C

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-16 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

CT
Korean KRGDB
C 20.5% · T 79.5%
Korean Korea4K
C 20.1% · T 79.9%
Japanese ToMMo
C 19.4% · T 80.6%
Vietnamese
C 17.2% · T 82.8%
World gnomAD
C 25.4% · T 74.6%
World 1000 Genomes
C 38.2% · T 61.8%
World TOPMed
C 25.4% · T 74.6%

By ancestry gnomAD

East Asian
C 20.6% · T 79.4%
European (non-Finnish)
C 23.9% · T 76.1%
African / African American
C 30.2% · T 69.8%
South Asian
C 22.1% · T 77.9%
Admixed American (Latino)
C 22.6% · T 77.4%
Middle Eastern
C 23.1% · T 76.9%
Finnish
C 22.1% · T 77.9%
Ashkenazi Jewish
C 30.6% · T 69.4%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C Two copies of the version the research linked to Metabolic syndrome (bivariate traits). That is the strongest link of the three results. A link in a study is not a diagnosis.
C/T One copy of the version the research linked to Metabolic syndrome (bivariate traits). That is a smaller link than two copies.
T/T No copy of the version the research linked to Metabolic syndrome (bivariate traits). This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Metabolic syndrome (bivariate traits) (rs301). MyGeneLog™. https://www.mygenelog.com/variants/rs301

← See all variants